心律管理設備市場規模、佔有率、成長分析、按產品、按最終用戶、按地區 - 行業預測，2024-2031 年

Cardiac Rhythm Management Devices Market Size, Share, Growth Analysis, By Product (Pacemakers, Defibrillators), By End User (Hospitals & Clinics, Ambulatory Surgery Centers), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年心律管理設備的市場規模為188億美元，從2023年的198.3億美元成長到2031年的304.4億美元，預計在預測期內（2024-2031年）複合年成長率為5.5%。

由於心房顫動、心律不整和心臟衰竭等心血管疾病盛行率不斷上升，以及對有效治療解決方案的需求不斷增加，心律管理設備市場正在經歷強勁成長。人口老化進一步加劇了這一趨勢，而人口老化本來就更容易罹患心臟相關疾病。技術進步，特別是在設備小型化、無線連接和先進演算法方面的進步，大大提高了這些設備的性能和準確性。植入式心臟整流去顫器(ICD)、心律調節器和心臟再同步治療 (CRT) 等創新治療方法的出現徹底改變了心律不整的治療。競爭格局正在發生變化，Medtronic plc、Abbott Laboratories、Boston Scientific Corporation、Biotronik SE &Co.KG 和 St. Jude Medical, Inc. 等主要企業專注於研發以推動創新並確保其市場地位。因此，由於心血管疾病盛行率不斷上升、技術不斷進步以及老年人口不斷成長，全球心律管理設備市場預計將保持其成長軌跡。隨著診斷和治療能力的不斷進步，改善患者的治療效果和生活品質，預計美國市場在未來幾年將出現持續的複合年成長率。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Physio-Control, Inc.（Stryker）（US）
BIOTRONIK（Germany）
Schiller（Switzerland）
Medtronic（US）
Abbott（US）
Koninklijke Philips NV（Netherlands）
Zoll Medical Corporation（US）
Boston Scientific Corporation（US）
Progetti Srl（Italy）
LivaNova Plc（UK）
Impella（ABIOMED, US）
AngioDynamics, Inc.（US）
MicroPort Scientific Corporation（China）
Edwards Lifesciences Corporation（US）
Getinge AB（Sweden）
Synchrony Medical（US）
Osypka AG（Germany）
Inspire Medical Systems, Inc.（US）
AtriCure, Inc.（US）
Apex Medical（Taiwan）
Biotronik SE & Co. KG（Germany）
VivaSonic Inc.（US）

簡介目錄

Product Code: SQMIG35A2577

Cardiac Rhythm Management Devices Market size was valued at USD 18.80 billion in 2022 and is poised to grow from USD 19.83 billion in 2023 to USD 30.44 billion by 2031, at a CAGR of 5.5% during the forecast period (2024-2031)

The cardiac rhythm management devices market is experiencing robust growth, propelled by the rising incidence of cardiovascular conditions such as atrial fibrillation, arrhythmias, and heart failure, leading to an increased demand for effective treatment solutions. This trend is further amplified by the expanding geriatric population, which is inherently more vulnerable to heart-related ailments. Technological advancements, particularly in device miniaturization, wireless connectivity, and sophisticated algorithms, have significantly enhanced the performance and accuracy of these devices. The emergence of innovative treatments, such as implantable cardioverter-defibrillators (ICDs), pacemakers, and cardiac resynchronization therapy (CRT), has transformed the management of cardiac rhythm disorders. The competitive landscape is marked by key players such as Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, and St. Jude Medical, Inc., who are heavily investing in research and development to drive innovation and secure their market positions. As a result, the global cardiac rhythm management devices market is projected to sustain its growth trajectory, driven by a confluence of increasing cardiovascular disease prevalence, ongoing technological enhancement, and a growing older population. In particular, the U.S. market is anticipated to experience sustainable compound annual growth rate (CAGR) in the forthcoming years, with continual advancements set to bolster diagnosis and treatment capabilities, thereby enhancing overall patient outcomes and quality of life.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiac Rhythm Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiac Rhythm Management Devices Market Segmental Analysis

Global Cardiac Rhythm Management Devices Market is segmented by Product, End User, and region. Based on Product, the market is segmented into Pacemakers, and Defibrillators. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgery Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cardiac Rhythm Management Devices Market

The alarming rise in physical inactivity, identified as the second leading cause of death in the US, is a significant market driver for the Cardiac Rhythm Management Devices market. With sedentary lifestyles contributing to a heightened prevalence of chronic diseases such as diabetes and cardiovascular disorders, there is an increasing need for effective monitoring and management solutions. The World Health Organization's estimate of approximately 2 million deaths annually due to inactivity underscores the urgency for advanced cardiac devices. As more individuals become affected by heart conditions linked to a lack of exercise, demand for innovative cardiac rhythm management technologies is projected to surge in both developed and developing nations.

Restraints in the Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices market faces significant restraints primarily due to the high costs associated with these advanced technologies, which can limit accessibility for both patients and healthcare providers, particularly in developing regions. Furthermore, the shortage of qualified healthcare professionals trained in the usage and maintenance of these devices exacerbates the issue, hindering optimal patient care and device efficacy. Additionally, the limited number of healthcare facilities capable of providing such specialized treatments further dampens market growth. Collectively, these factors contribute to a restrictive environment for market expansion in regions that critically need improved cardiac care solutions.

Market Trends of the Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices market is witnessing a significant trend towards personalized medicine, emphasizing the customization of treatment strategies to align with individual patient profiles. This shift is fueled by the development of advanced devices equipped with adaptive algorithms and machine learning capabilities, which enable healthcare providers to deliver tailored therapies that enhance patient outcomes. As a result, there is growing investment in innovative technologies that can analyze real-time data and adjust treatment protocols, fostering a more precise approach to managing cardiac conditions. This trend not only improves patient engagement but also drives market growth and competitiveness within the sector.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Cardiac Rhythm Management Devices Market by Product

Market Overview
Pacemakers
- Implantable
- External
Defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- S-ICD
- T-ICD
- External Defibrillator
- Manual External Defibrillator
- Automatic External Defibrillator
- Wearable Cardioverter Defibrillator
- Cardiac Resynchronization Therapy (CRT)
- CRT-Defibrillator
- CRT-Pacemakers

Cardiac Rhythm Management Devices Market by End User

Market Overview
Hospitals & Clinics
Ambulatory Surgery Centers
Others

Cardiac Rhythm Management Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Physio-Control, Inc. (Stryker) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schiller (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoll Medical Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progetti Srl (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Impella (ABIOMED, US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synchrony Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inspire Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apex Medical (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VivaSonic Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments